Literature DB >> 21463023

Nucleus accumbens dopamine modulates response rate but not response timing in an interval timing task.

Allison N Kurti1, Matthew S Matell.   

Abstract

While previous work has demonstrated that systemic dopamine manipulations can modulate temporal perception by altering the speed of internal clock processes, the neural site of this modulation remains unclear. Based on recent research suggesting that changes in incentive salience can alter the perception of time, as well as work showing that nucleus accumbens (NAc) shell dopamine (DA) levels modulate the incentive salience of discriminative stimuli that predict instrumental outcomes, we assessed whether microinjections of DA agents into the NAc shell would impact temporal perception. Rats were trained on either a 10-s or 30-s temporal production procedure and received intra-NAc shell microinfusions of sulpiride, amphetamine, and saline. Results showed that NAc DA modulations had no effect on response timing, but intra-NAc shell sulpiride microinfusions significantly decreased response rates relative to saline and amphetamine. Our findings therefore suggest that neither NAc shell DA levels, nor the resultant changes in incentive salience signaled by this structure, impact temporal control. (PsycINFO Database Record (c) 2011 APA, all rights reserved).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21463023      PMCID: PMC3072872          DOI: 10.1037/a0022892

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  75 in total

1.  Method for training operant responding and evaluating cocaine self-administration behavior in mutant mice.

Authors:  S B Caine; S S Negus; N K Mello
Journal:  Psychopharmacology (Berl)       Date:  1999-11       Impact factor: 4.530

Review 2.  Mesolimbocortical and nigrostriatal dopamine responses to salient non-reward events.

Authors:  J C Horvitz
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

Review 3.  Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens.

Authors:  S M Nicola; J Surmeier; R C Malenka
Journal:  Annu Rev Neurosci       Date:  2000       Impact factor: 12.449

Review 4.  Time, rate, and conditioning.

Authors:  C R Gallistel; J Gibbon
Journal:  Psychol Rev       Date:  2000-04       Impact factor: 8.934

Review 5.  Neuropsychological mechanisms of interval timing behavior.

Authors:  M S Matell; W H Meck
Journal:  Bioessays       Date:  2000-01       Impact factor: 4.345

Review 6.  Varieties of impulsivity.

Authors:  J L Evenden
Journal:  Psychopharmacology (Berl)       Date:  1999-10       Impact factor: 4.530

Review 7.  Theory and method in the quantitative analysis of "impulsive choice" behaviour: implications for psychopharmacology.

Authors:  M Y Ho; S Mobini; T J Chiang; C M Bradshaw; E Szabadi
Journal:  Psychopharmacology (Berl)       Date:  1999-10       Impact factor: 4.530

Review 8.  What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?

Authors:  K C Berridge; T E Robinson
Journal:  Brain Res Brain Res Rev       Date:  1998-12

Review 9.  The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking.

Authors:  S Ikemoto; J Panksepp
Journal:  Brain Res Brain Res Rev       Date:  1999-12

10.  The role of accumbens dopamine in lever pressing and response allocation: effects of 6-OHDA injected into core and dorsomedial shell.

Authors:  J D Sokolowski; J D Salamone
Journal:  Pharmacol Biochem Behav       Date:  1998-03       Impact factor: 3.533

View more
  12 in total

1.  Hippocampus, time, and memory--a retrospective analysis.

Authors:  Warren H Meck; Russell M Church; Matthew S Matell
Journal:  Behav Neurosci       Date:  2013-10       Impact factor: 1.912

2.  Prefrontal D1 dopamine signaling is required for temporal control.

Authors:  Nandakumar S Narayanan; Benjamin B Land; John E Solder; Karl Deisseroth; Ralph J DiLeone
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-26       Impact factor: 11.205

3.  Interval timing, temporal averaging, and cue integration.

Authors:  Benjamin J De Corte; Matthew S Matell
Journal:  Curr Opin Behav Sci       Date:  2016-04

4.  Effects of nucleus accumbens amphetamine administration on performance in a delay discounting task.

Authors:  Caitlin A Orsini; Marci R Mitchell; Sara C Heshmati; Kristy G Shimp; Megan S Spurrell; Jennifer L Bizon; Barry Setlow
Journal:  Behav Brain Res       Date:  2017-01-03       Impact factor: 3.332

5.  Reinforcement probability modulates temporal memory selection and integration processes.

Authors:  Matthew S Matell; Allison N Kurti
Journal:  Acta Psychol (Amst)       Date:  2013-07-27

6.  Prefrontal cortical-striatal dopamine receptor mRNA expression predicts distinct forms of impulsivity.

Authors:  Nicholas W Simon; Blanca S Beas; Karienn S Montgomery; Rebecca P Haberman; Jennifer L Bizon; Barry Setlow
Journal:  Eur J Neurosci       Date:  2013-03-20       Impact factor: 3.386

7.  Dissociations between interval timing and intertemporal choice following administration of fluoxetine, cocaine, or methamphetamine.

Authors:  Sarah R Heilbronner; Warren H Meck
Journal:  Behav Processes       Date:  2013-10-14       Impact factor: 1.777

8.  Acquisition of "Start" and "Stop" response thresholds in peak-interval timing is differentially sensitive to protein synthesis inhibition in the dorsal and ventral striatum.

Authors:  Christopher J Macdonald; Ruey-Kuang Cheng; Warren H Meck
Journal:  Front Integr Neurosci       Date:  2012-03-14

Review 9.  Executive dysfunction in Parkinson's disease and timing deficits.

Authors:  Krystal L Parker; Dronacharya Lamichhane; Marcelo S Caetano; Nandakumar S Narayanan
Journal:  Front Integr Neurosci       Date:  2013-10-31

Review 10.  Endocannabinoid-dependent modulation of phasic dopamine signaling encodes external and internal reward-predictive cues.

Authors:  Jennifer M Wenzel; Joseph F Cheer
Journal:  Front Psychiatry       Date:  2014-09-01       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.